Home
BNTC
BNTC News

Latest Benitec Biopharma Inc. (BNTC) News on November 20, 2025

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment

Insider Monkey

2 days ago

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment

Hedge funds investors have a lot riding on Benitec Biopharma Inc. (NASDAQ:BNTC) with 37% ownership

Simply Wall St.

2 days ago

Hedge funds investors have a lot riding on Benitec Biopharma Inc. (NASDAQ:BNTC) with 37% ownership

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

GlobeNewswire

6 days ago

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

Big Insider Purchases by Carl Icahn, Mario Gabelli, and Others

24/7 Wall St.

8 days ago

Big Insider Purchases by Carl Icahn, Mario Gabelli, and Others

Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering

GlobeNewswire

14 days ago

Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering

Benitec Biopharma Inc. Announces Proposed Public Offering

GlobeNewswire

15 days ago

Benitec Biopharma Inc. Announces Proposed Public Offering

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301

GlobeNewswire

17 days ago

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301

Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

GlobeNewswire

17 days ago

Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy

GlobeNewswire

18 days ago

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy

AWS outage impacts Coinbase, Robinhood: What we know

Yahoo Finance Video

a month ago

AWS outage impacts Coinbase, Robinhood: What we know

Stock market today: Dow, S&P 500, Nasdaq rise amid trade-war lull, with flurry of earnings on deck

Yahoo Finance

a month ago

Stock market today: Dow, S&P 500, Nasdaq rise amid trade-war lull, with flurry of earnings on deck

AWS outage, futures rise, CPI report this week: 3 Things

Yahoo Finance Video

a month ago

AWS outage, futures rise, CPI report this week: 3 Things

Gold price today, Monday, October 20: Gold opens at $4,269 after Friday’s all-time high

Yahoo Personal Finance

a month ago

Gold price today, Monday, October 20: Gold opens at $4,269 after Friday’s all-time high

Earnings live: Tesla, Netflix, General Motors, Ford, and P&G to headline third quarter earnings calendar this week

Yahoo Finance

a month ago

Earnings live: Tesla, Netflix, General Motors, Ford, and P&G to headline third quarter earnings calendar this week

Beyond Meat, Tesla, TKMS, Kering: Trending Stocks

Yahoo Finance Video

a month ago

Beyond Meat, Tesla, TKMS, Kering: Trending Stocks

Busy week of earnings ahead: Tesla, Intel, Coca-Cola, Netflix

Yahoo Finance Video

a month ago

Busy week of earnings ahead: Tesla, Intel, Coca-Cola, Netflix

How to financially survive a job furlough

Yahoo Personal Finance

a month ago

How to financially survive a job furlough

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Zacks

5 months ago

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?

Zacks

5 months ago

Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?

Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year?

Zacks

6 months ago

Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year?

Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet

Zacks

6 months ago

Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet

Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year?

Zacks

6 months ago

Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year?

Benitec Biopharma Releases Third Quarter 2025 Financial Results

GlobeNewswire

6 months ago

Benitec Biopharma Releases Third Quarter 2025 Financial Results

Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

7 months ago

Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why

Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year?

Zacks

7 months ago

Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year?

Wall Street Analysts Believe Benitec Biopharma (BNTC) Could Rally 84.96%: Here's is How to Trade

Zacks

7 months ago

Wall Street Analysts Believe Benitec Biopharma (BNTC) Could Rally 84.96%: Here's is How to Trade

What Makes Benitec Biopharma (BNTC) a New Buy Stock

Zacks

7 months ago

What Makes Benitec Biopharma (BNTC) a New Buy Stock

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?

Zacks

7 months ago

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?

MT Newswires

8 months ago

Benitec Biopharma Prices $30 Million Equity Offerings

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering

GlobeNewswire

8 months ago

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

GlobeNewswire

8 months ago

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Has Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?

Zacks

8 months ago

Has Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

8 months ago

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans

Benitec Biopharma to Participate in Upcoming Conferences in March

GlobeNewswire

9 months ago

Benitec Biopharma to Participate in Upcoming Conferences in March

Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know

Zacks

9 months ago

Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update

GlobeNewswire

9 months ago

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference

GlobeNewswire

9 months ago

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference

Benitec Biopharma to Participate in Upcoming Conferences in January and February

GlobeNewswire

10 months ago

Benitec Biopharma to Participate in Upcoming Conferences in January and February

Why You Shouldn't Bet Against Benitec Biopharma (BNTC) Stock

Zacks

10 months ago

Why You Shouldn't Bet Against Benitec Biopharma (BNTC) Stock

Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC)

Simply Wall St.

a year ago

Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC)

Benitec Biopharma initiated with a Buy at H.C. Wainwright

TipRanks

a year ago

Benitec Biopharma initiated with a Buy at H.C. Wainwright

MT Newswires

a year ago

HC Wainwright Initiates Benitec Biopharma at Buy With $28 Price Target

MT Newswires

a year ago

Baird Initiates Benitec Biopharma at Outperform With $30 Price Target

Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?

Zacks

a year ago

Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?

Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

a year ago

Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why

Benitec Biopharma to Participate in Upcoming Investor Conferences in December

GlobeNewswire

a year ago

Benitec Biopharma to Participate in Upcoming Investor Conferences in December

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

GlobeNewswire

a year ago

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

GlobeNewswire

a year ago

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

Janus Henderson Group PLC Expands Investment in Benitec Biopharma Inc

GuruFocus.com

a year ago

Janus Henderson Group PLC Expands Investment in Benitec Biopharma Inc

Benitec Biopharma Announces Updated Investor Webcast Information

GlobeNewswire

a year ago

Benitec Biopharma Announces Updated Investor Webcast Information

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

GlobeNewswire

a year ago

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc

GuruFocus.com

a year ago

Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

a year ago

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update

GlobeNewswire

a year ago

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update

Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society

GlobeNewswire

a year ago

Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society

Benitec Biopharma CEO to Participate in OPMD Awareness Day Webinar

GlobeNewswire

a year ago

Benitec Biopharma CEO to Participate in OPMD Awareness Day Webinar

Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study

GlobeNewswire

a year ago

Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study

Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors

GlobeNewswire

a year ago

Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors

Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire

2 years ago

Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference

GlobeNewswire

2 years ago

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

GlobeNewswire

2 years ago

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

GlobeNewswire

2 years ago

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024

GlobeNewswire

2 years ago

Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024

11 Best ASX Stocks To Buy Now

Insider Monkey

2 years ago

11 Best ASX Stocks To Buy Now

Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire

2 years ago

Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update

Knightscope Earns Triple Expansion of Emergency Communications Tech

Business Wire

2 years ago

Knightscope Earns Triple Expansion of Emergency Communications Tech

Foresight: Rail Vision Reveals its Next Generation AI Computer for Railway Safety and Accident Prevention

GlobeNewswire

2 years ago

Foresight: Rail Vision Reveals its Next Generation AI Computer for Railway Safety and Accident Prevention

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology

GlobeNewswire

2 years ago

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology

Ford And GM Expect EVs Will Stall For A While, But Stellantis, Tesla And Worksport Don't Think That Will Be The Case

Benzinga

2 years ago

Ford And GM Expect EVs Will Stall For A While, But Stellantis, Tesla And Worksport Don't Think That Will Be The Case

Worksport Subsidiary Terravis Energy Starts To Build Heat Pump Supply Chain

GlobeNewswire

2 years ago

Worksport Subsidiary Terravis Energy Starts To Build Heat Pump Supply Chain

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 years ago

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Bridgewater Bancshares Inc Earnings Call

Chemung Financial (CHMG) Q4 Earnings Lag Estimates

Zacks

2 years ago

Chemung Financial (CHMG) Q4 Earnings Lag Estimates

Associated Press Finance

2 years ago

Chemung Financial: Q4 Earnings Snapshot

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...

GuruFocus.com

2 years ago

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...

Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List

GlobeNewswire

2 years ago

Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List

Bridgewater Bancshares Inc (BWB) Reports Q4 Earnings Dip Amidst Market Challenges

GuruFocus.com

2 years ago

Bridgewater Bancshares Inc (BWB) Reports Q4 Earnings Dip Amidst Market Challenges

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

GlobeNewswire

2 years ago

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

Chuck Royce's Firm Adds to Stake in Lakeland Industries Inc

GuruFocus.com

2 years ago

Chuck Royce's Firm Adds to Stake in Lakeland Industries Inc

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

ACCESSWIRE

2 years ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Lee Enterprises plans quarterly call and webcast February 1, 2024

GlobeNewswire

2 years ago

Lee Enterprises plans quarterly call and webcast February 1, 2024

KWESST Micro Systems Announces Fiscal 2023 Financial Results

Newsfile

2 years ago

KWESST Micro Systems Announces Fiscal 2023 Financial Results

GlobeNewswire

2 years ago

WiMi Developed a Trimmed K-Means Algorithm to Detect Crypto Wallet Fraud on the Bitcoin Network

EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

GlobeNewswire

2 years ago

EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

Simply Wall St.

2 years ago

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

Banle Energy International Limited Supports BYD's Maiden Voyage of Car Carrier, BYD Explorer 1

GlobeNewswire

2 years ago

Banle Energy International Limited Supports BYD's Maiden Voyage of Car Carrier, BYD Explorer 1

VCI Global Announces Pricing of $2.75 Million Public Offering

GlobeNewswire

2 years ago

VCI Global Announces Pricing of $2.75 Million Public Offering

GeneDx Announces Preliminary 2023 Financial Results

GlobeNewswire

2 years ago

GeneDx Announces Preliminary 2023 Financial Results

Royalty Management Holding Corporation Announces Update with Pilot Scale Permanent Magnet Metal Alloys Program with Advanced Magnet Lab, Inc.

ACCESSWIRE

2 years ago

Royalty Management Holding Corporation Announces Update with Pilot Scale Permanent Magnet Metal Alloys Program with Advanced Magnet Lab, Inc.

Healthcare Triangle, Inc. to Participate at the 2024 MUSE Executive Institute

GlobeNewswire

2 years ago

Healthcare Triangle, Inc. to Participate at the 2024 MUSE Executive Institute

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

GlobeNewswire

2 years ago

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering

GlobeNewswire

2 years ago

Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

GlobeNewswire

2 years ago

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

Here's Why We Think Central Valley Community Bancorp (NASDAQ:CVCY) Might Deserve Your Attention Today

Simply Wall St.

2 years ago

Here's Why We Think Central Valley Community Bancorp (NASDAQ:CVCY) Might Deserve Your Attention Today

Business Wire

2 years ago

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023

Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

CNW Group

2 years ago

Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

PR Newswire

2 years ago

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

PR Newswire

2 years ago

Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Cosmos Health Announces Open Market Stock Purchases by the CEO

ACCESSWIRE

2 years ago

Cosmos Health Announces Open Market Stock Purchases by the CEO

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth

InvestorPlace

2 years ago

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth

Share on Social Networks: